Pictet Asset Management (Switzerland)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$179M	Buy
2023 Q1	$200M	Buy
2022 Q4	$153M	Buy
2022 Q3	$65.1M	Buy
2022 Q2	$40.7M	Buy
2022 Q1	$36.9M	Sell
2021 Q4	$43M	Sell
2021 Q3	$58.3M	Buy